To improve the website's functionality, we use cookies, including third-party cookies. Read our Privacy Policy for more information

I Agree

Lung Cancer Diagnostics Market

Lung Cancer Diagnostics Market Analysis by Test Type (CA Test, HER2 Tests, ALK Tests, Angiogenesis Inhibitor, EGFR Mutation Tests), by Indication (Non-Small-cell Lung Cancer Diagnostics, Small-cell Lung Cancer Diagnostics), by End-User, by Region - Global Forecast 2021-2031

Analysis of Lung Cancer Diagnostics market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Request FREE Sample
Request FREE Customization

Table of Content

Chapter 1. Global Lung Cancer Diagnostics Market - Executive Summary. 12

Chapter 2. Global Lung Cancer Diagnostics Market Overview. 14

2.1. Introduction. 14

       2.1.1. Global Lung Cancer Diagnostics Market Taxonomy. 14

       2.1.2. Global Lung Cancer Diagnostics Market Definition. 14

2.2. Global Lung Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2016-2031. 15

       2.2.1. Global Lung Cancer Diagnostics Market Y-o-Y Growth. 15

2.3. Global Lung Cancer Diagnostics Market Dynamics. 15

       2.3.1. Drivers. 15

       2.3.2. Restraints. 15

       2.3.3. Trends. 16

2.4. Supply Chain. 16

2.5. Key Participants Market Presence (Intensity Map) By Region. 16

Chapter 3. Global Lung Cancer Diagnostics Market Analysis and Forecast By Test Type. 17

3.1. Global Lung Cancer Diagnostics Market Size and Forecast By Test Type, 2016-2031. 17

       3.1.1. CA Test Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 17

                3.1.1.1. Revenue (US$ Mn) Comparison, By Region. 17

                3.1.1.2. Market Share Comparison, By Region. 19

                3.1.1.3. Y-o-Y growth Comparison, By Region. 19

       3.1.2. HER2 Tests Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 20

                3.1.2.1. Revenue (US$ Mn) Comparison, By Region. 20

                3.1.2.2. Market Share Comparison, By Region. 22

                3.1.2.3. Y-o-Y growth Comparison, By Region. 22

       3.1.3. ALK Tests Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 23

                3.1.3.1. Revenue (US$ Mn) Comparison, By Region. 23

                3.1.3.2. Market Share Comparison, By Region. 25

                3.1.3.3. Y-o-Y growth Comparison, By Region. 25

       3.1.4. Angiogenesis Inhibitor Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 26

                3.1.4.1. Revenue (US$ Mn) Comparison, By Region. 26

                3.1.4.2. Market Share Comparison, By Region. 28

                3.1.4.3. Y-o-Y growth Comparison, By Region. 28

       3.1.5. EGFR Mutation Tests Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 29

                3.1.5.1. Revenue (US$ Mn) Comparison, By Region. 29

                3.1.5.2. Market Share Comparison, By Region. 31

                3.1.5.3. Y-o-Y growth Comparison, By Region. 31

       3.1.6. KRAS Mutation Tests Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 32

                3.1.6.1. Revenue (US$ Mn) Comparison, By Region. 32

                3.1.6.2. Market Share Comparison, By Region. 34

                3.1.6.3. Y-o-Y growth Comparison, By Region. 34

       3.1.7. Others Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 35

                3.1.7.1. Revenue (US$ Mn) Comparison, By Region. 35

                3.1.7.2. Market Share Comparison, By Region. 37

                3.1.7.3. Y-o-Y growth Comparison, By Region. 37

Chapter 4. Global Lung Cancer Diagnostics Market Analysis and Forecast By End User. 39

4.1. Global Lung Cancer Diagnostics Market Size and Forecast By End User, 2016-2031. 39

       4.1.1. Hospital Associated Labs Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 39

                4.1.1.1. Revenue (US$ Mn) Comparison, By Region. 39

                4.1.1.2. Market Share Comparison, By Region. 41

                4.1.1.3. Y-o-Y growth Comparison, By Region. 41

       4.1.2. Independent Diagnostic Laboratories Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 42

                4.1.2.1. Revenue (US$ Mn) Comparison, By Region. 42

                4.1.2.2. Market Share Comparison, By Region. 44

                4.1.2.3. Y-o-Y growth Comparison, By Region. 44

       4.1.3. Cancer Research Institutes Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 45

                4.1.3.1. Revenue (US$ Mn) Comparison, By Region. 45

                4.1.3.2. Market Share Comparison, By Region. 47

                4.1.3.3. Y-o-Y growth Comparison, By Region. 47

       4.1.4. Others Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 48

                4.1.4.1. Revenue (US$ Mn) Comparison, By Region. 48

                4.1.4.2. Market Share Comparison, By Region. 50

                4.1.4.3. Y-o-Y growth Comparison, By Region. 50

Chapter 5. Global Lung Cancer Diagnostics Market Analysis and Forecast By Indication. 52

5.1. Global Lung Cancer Diagnostics Market Size and Forecast By Indication, 2016-2031. 52

       5.1.1. Non Small-cell Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 52

                5.1.1.1. Revenue (US$ Mn) Comparison, By Region. 52

                5.1.1.2. Market Share Comparison, By Region. 54

                5.1.1.3. Y-o-Y growth Comparison, By Region. 54

       5.1.2. Small-cell Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 55

                5.1.2.1. Revenue (US$ Mn) Comparison, By Region. 55

                5.1.2.2. Market Share Comparison, By Region. 57

                5.1.2.3. Y-o-Y growth Comparison, By Region. 57

Chapter 6. Global Lung Cancer Diagnostics Market Analysis and Forecast By Region. 59

6.1. Global Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 59

       6.1.1. North America Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 59

                6.1.1.1. Revenue (US$ Mn) Comparison, By Test Type. 59

                6.1.1.2. Revenue (US$ Mn) Comparison, By End User. 61

                6.1.1.3. Revenue (US$ Mn) Comparison, By Indication. 62

       6.1.2. Latin America Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 64

                6.1.2.1. Revenue (US$ Mn) Comparison, By Test Type. 64

                6.1.2.2. Revenue (US$ Mn) Comparison, By Indication. 67

       6.1.3. Europe Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 69

                6.1.3.1. Revenue (US$ Mn) Comparison, By Test Type. 69

                6.1.3.2. Revenue (US$ Mn) Comparison, By End User. 71

                6.1.3.3. Revenue (US$ Mn) Comparison, By Indication. 72

       6.1.4. Japan Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 74

                6.1.4.1. Revenue (US$ Mn) Comparison, By Test Type. 74

                6.1.4.2. Revenue (US$ Mn) Comparison, By Indication. 77

       6.1.5. APEJ Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 79

                6.1.5.1. Revenue (US$ Mn) Comparison, By Test Type. 79

                6.1.5.2. Revenue (US$ Mn) Comparison, By End User. 81

                6.1.5.3. Revenue (US$ Mn) Comparison, By Indication. 82

       6.1.6. MEA Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 84

                6.1.6.1. Revenue (US$ Mn) Comparison, By Test Type. 84

                6.1.6.2. Revenue (US$ Mn) Comparison, By End User. 86

                6.1.6.3. Revenue (US$ Mn) Comparison, By Indication. 87

Chapter 7. North America Lung Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031. 90

7.1. US Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 90

       7.1.1. Revenue (US$ Mn) Comparison, By Test Type. 90

       7.1.2. Revenue (US$ Mn) Comparison, By End User. 91

       7.1.3. Revenue (US$ Mn) Comparison, By Indication. 91

7.2. Canada Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 92

       7.2.1. Revenue (US$ Mn) Comparison, By Test Type. 92

       7.2.2. Revenue (US$ Mn) Comparison, By End User. 93

       7.2.3. Revenue (US$ Mn) Comparison, By Indication. 94

Chapter 8. Latin America Lung Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031. 96

8.1. Brazil Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 96

       8.1.1. Revenue (US$ Mn) Comparison, By Test Type. 96

       8.1.2. Revenue (US$ Mn) Comparison, By End User. 97

       8.1.3. Revenue (US$ Mn) Comparison, By Indication. 97

8.2. Mexico Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 98

       8.2.1. Revenue (US$ Mn) Comparison, By Test Type. 98

       8.2.2. Revenue (US$ Mn) Comparison, By End User. 99

       8.2.3. Revenue (US$ Mn) Comparison, By Indication. 100

8.3. Argentina Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 101

       8.3.1. Revenue (US$ Mn) Comparison, By Test Type. 101

       8.3.2. Revenue (US$ Mn) Comparison, By End User. 102

       8.3.3. Revenue (US$ Mn) Comparison, By Indication. 103

Chapter 9. Europe Lung Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031. 104

9.1. Germany Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 104

       9.1.1. Revenue (US$ Mn) Comparison, By Test Type. 104

       9.1.2. Revenue (US$ Mn) Comparison, By End User. 105

       9.1.3. Revenue (US$ Mn) Comparison, By Indication. 106

9.2. UK Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 106

       9.2.1. Revenue (US$ Mn) Comparison, By Test Type. 106

       9.2.2. Revenue (US$ Mn) Comparison, By End User. 107

       9.2.3. Revenue (US$ Mn) Comparison, By Indication. 108

9.3. France Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 109

       9.3.1. Revenue (US$ Mn) Comparison, By Test Type. 109

       9.3.2. Revenue (US$ Mn) Comparison, By End User. 110

       9.3.3. Revenue (US$ Mn) Comparison, By Indication. 111

9.4. Spain Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 111

       9.4.1. Revenue (US$ Mn) Comparison, By Test Type. 111

       9.4.2. Revenue (US$ Mn) Comparison, By End User. 112

       9.4.3. Revenue (US$ Mn) Comparison, By Indication. 113

9.5. Italy Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 114

       9.5.1. Revenue (US$ Mn) Comparison, By Test Type. 114

       9.5.2. Revenue (US$ Mn) Comparison, By End User. 115

       9.5.3. Revenue (US$ Mn) Comparison, By Indication. 116

9.6. Nordic Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 116

       9.6.1. Revenue (US$ Mn) Comparison, By Test Type. 116

       9.6.2. Revenue (US$ Mn) Comparison, By End User. 117

       9.6.3. Revenue (US$ Mn) Comparison, By Indication. 118

Chapter 10. Japan Lung Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031. 120

10.1. Japan  Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 120

       10.1.1. Revenue (US$ Mn) Comparison, By Test Type. 120

       10.1.2. Revenue (US$ Mn) Comparison, By End User. 121

       10.1.3. Revenue (US$ Mn) Comparison, By Indication. 121

Chapter 11. APEJ Lung Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031. 123

11.1. China Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 123

       11.1.1. Revenue (US$ Mn) Comparison, By Test Type. 123

       11.1.2. Revenue (US$ Mn) Comparison, By End User. 124

       11.1.3. Revenue (US$ Mn) Comparison, By Indication. 124

11.2. India Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 125

       11.2.1. Revenue (US$ Mn) Comparison, By Test Type. 125

       11.2.2. Revenue (US$ Mn) Comparison, By End User. 126

       11.2.3. Revenue (US$ Mn) Comparison, By Indication. 127

11.3. Malaysia Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 128

       11.3.1. Revenue (US$ Mn) Comparison, By Test Type. 128

       11.3.2. Revenue (US$ Mn) Comparison, By End User. 129

       11.3.3. Revenue (US$ Mn) Comparison, By Indication. 130

11.4. Thailand Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 130

       11.4.1. Revenue (US$ Mn) Comparison, By Test Type. 130

       11.4.2. Revenue (US$ Mn) Comparison, By End User. 131

       11.4.3. Revenue (US$ Mn) Comparison, By Indication. 132

11.5. Singapore Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 133

       11.5.1. Revenue (US$ Mn) Comparison, By Test Type. 133

       11.5.2. Revenue (US$ Mn) Comparison, By End User. 134

       11.5.3. Revenue (US$ Mn) Comparison, By Indication. 135

11.6. Australia Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 136

       11.6.1. Revenue (US$ Mn) Comparison, By Test Type. 136

       11.6.2. Revenue (US$ Mn) Comparison, By End User. 137

       11.6.3. Revenue (US$ Mn) Comparison, By Indication. 137

Chapter 12. MEA Lung Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031. 139

12.1. GCC Countries Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 139

       12.1.1. Revenue (US$ Mn) Comparison, By Test Type. 139

       12.1.2. Revenue (US$ Mn) Comparison, By End User. 140

       12.1.3. Revenue (US$ Mn) Comparison, By Indication. 141

12.2. South Africa Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 141

       12.2.1. Revenue (US$ Mn) Comparison, By Test Type. 141

       12.2.2. Revenue (US$ Mn) Comparison, By End User. 142

       12.2.3. Revenue (US$ Mn) Comparison, By Indication. 143

12.3. Nigeria Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 144

       12.3.1. Revenue (US$ Mn) Comparison, By Test Type. 144

       12.3.2. Revenue (US$ Mn) Comparison, By End User. 145

       12.3.3. Revenue (US$ Mn) Comparison, By Indication. 146

12.4. Israel Lung Cancer Diagnostics Market Size and Forecast, 2016-2031. 146

       12.4.1. Revenue (US$ Mn) Comparison, By Test Type. 146

       12.4.2. Revenue (US$ Mn) Comparison, By End User. 147

       12.4.3. Revenue (US$ Mn) Comparison, By Indication. 148

Chapter 13. Global Lung Cancer Diagnostics Market Company/Manufactures/Distributors/Suppliers Profile and Revenue Projections. 150

13.1. Illumina, Inc.. 150

       13.1.1. Company Overview. 150

       13.1.2. Product Overview. 151

       13.1.3. Key Financials. 151

       13.1.4. Key Developments. 151

       13.1.5. SWOT Analysis. 151

13.2. Abbott Laboratories. 153

       13.2.1. Company Overview. 153

       13.2.2. Product Overview. 153

       13.2.3. Key Financials. 153

       13.2.4. Key Developments. 154

       13.2.5. SWOT Analysis. 154

13.3. Thermo Fisher Scientific, Inc. 155

       13.3.1. Company Overview. 155

       13.3.2. Product Overview. 155

       13.3.3. Key Financials. 155

       13.3.4. Key Developments. 156

       13.3.5. SWOT Analysis. 156

13.4. QIAGEN N.V.. 157

       13.4.1. Company Overview. 157

       13.4.2. Product Overview. 157

       13.4.3. Key Financials. 158

13.5. Quest Diagnostics Incorporated. 159

       13.5.1. Company Overview. 159

       13.5.2. Product Overview. 159

       13.5.3. Key Financials. 159

       13.5.4. SWOT Analysis. 160

13.6. NeoGenomics Laboratories, Inc.. 162

       13.6.1. Company Overview. 162

       13.6.2. Key Financials. 162

13.7. NanoString Technologies Inc. 163

       13.7.1. Company Overview. 163

       13.7.2. Product Overview. 163

       13.7.3. Key Financials. 164

13.8. Myriad Genetics Inc. 165

       13.8.1. Company Overview. 165

       13.8.2. Product Overview. 165

       13.8.3. Key Financials. 166

       13.8.4. SWOT Analysis. 166

13.9. Roche Holding AG.. 169

       13.9.1. Company Overview. 169

       13.9.2. Product Overview. 169

       13.9.3. Key Financials. 170

       13.9.4. Key Developments. 170

       13.9.5. SWOT Analysis. 170

13.10. Danaher Corporation. 174

       13.10.1. Company Overview. 174

       13.10.2. Product Overview. 174

       13.10.3. Key Financials. 175

       13.10.4. Key Developments. 175

       13.10.5. SWOT Analysis. 175

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

TABLE 1 Global Lung Cancer Diagnostics Market Value (US$ Mn), 2016-2020 29

TABLE 2 Global Lung Cancer Diagnostics Market Value (US$ Mn), 2021-2031 30

TABLE 3 Global Lung Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2015-2031 32

TABLE 4 Global CA Test Segment Value (US$ Mn), By Region 2016-2020 34

TABLE 5 Global CA Test Segment Value (US$ Mn), By Region 2021-2031 35

TABLE 6 Global CA Test Segment Market Share, By Region 2016-2020 36

TABLE 7 Global CA Test Segment Market Share, By Region 2021-2031 36

TABLE 8 Global CA Test Segment Y-o-Y, By Region 2015-2031 36

TABLE 9 Global HER2 Tests Segment Value (US$ Mn), By Region 2016-2020 37

TABLE 10 Global HER2 Tests Segment Value (US$ Mn), By Region 2021-2031 38

TABLE 11 Global HER2 Tests Segment Market Share, By Region 2016-2020 39

TABLE 12 Global HER2 Tests Segment Market Share, By Region 2021-2031 39

TABLE 13 Global HER2 Tests Segment Y-o-Y, By Region 2015-2031 39

TABLE 14 Global ALK Tests Segment Value (US$ Mn), By Region 2016-2020 40

TABLE 15 Global ALK Tests Segment Value (US$ Mn), By Region 2021-2031 41

TABLE 16 Global ALK Tests Segment Market Share, By Region 2016-2020 42

TABLE 17 Global ALK Tests Segment Market Share, By Region 2021-2031 42

TABLE 18 Global ALK Tests Segment Y-o-Y, By Region 2015-2031 42

TABLE 19 Global Angiogenesis Inhibitor Segment Value (US$ Mn), By Region 2016-2020 43

TABLE 20 Global Angiogenesis Inhibitor Segment Value (US$ Mn), By Region 2021-2031 44

TABLE 21 Global Angiogenesis Inhibitor Segment Market Share, By Region 2016-2020 45

TABLE 22 Global Angiogenesis Inhibitor Segment Market Share, By Region 2021-2031 45

TABLE 23 Global Angiogenesis Inhibitor Segment Y-o-Y, By Region 2015-2031 45

TABLE 24 Global EGFR Mutation Tests Segment Value (US$ Mn), By Region 2016-2020 46

TABLE 25 Global EGFR Mutation Tests Segment Value (US$ Mn), By Region 2021-2031 47

TABLE 26 Global EGFR Mutation Tests Segment Market Share, By Region 2016-2020 48

TABLE 27 Global EGFR Mutation Tests Segment Market Share, By Region 2021-2031 48

TABLE 28 Global EGFR Mutation Tests Segment Y-o-Y, By Region 2015-2031 48

TABLE 29 Global KRAS Mutation Tests Segment Value (US$ Mn), By Region 2016-2020 49

TABLE 30 Global KRAS Mutation Tests Segment Value (US$ Mn), By Region 2021-2031 50

TABLE 31 Global KRAS Mutation Tests Segment Market Share, By Region 2016-2020 51

TABLE 32 Global KRAS Mutation Tests Segment Market Share, By Region 2021-2031 51

TABLE 33 Global KRAS Mutation Tests Segment Y-o-Y, By Region 2015-2031 51

TABLE 34 Global Others Segment Value (US$ Mn), By Region 2016-2020 52

TABLE 35 Global Others Segment Value (US$ Mn), By Region 2021-2031 53

TABLE 36 Global Others Segment Market Share, By Region 2016-2020 54

TABLE 37 Global Others Segment Market Share, By Region 2021-2031 54

TABLE 38 Global Others Segment Y-o-Y, By Region 2015-2031 54

TABLE 39 Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2016-2020 56

TABLE 40 Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2021-2031 57

TABLE 41 Global Hospital Associated Labs Segment Market Share, By Region 2016-2020 58

TABLE 42 Global Hospital Associated Labs Segment Market Share, By Region 2021-2031 58

TABLE 43 Global Hospital Associated Labs Segment Y-o-Y, By Region 2015-2031 58

TABLE 44 Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2016-2020 59

TABLE 45 Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2021-2031 60

TABLE 46 Global Independent Diagnostic Laboratories Segment Market Share, By Region 2016-2020 61

TABLE 47 Global Independent Diagnostic Laboratories Segment Market Share, By Region 2021-2031 61

TABLE 48 Global Independent Diagnostic Laboratories Segment Y-o-Y, By Region 2015-2031 61

TABLE 49 Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2016-2020 62

TABLE 50 Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2021-2031 63

TABLE 51 Global Cancer Research Institutes Segment Market Share, By Region 2016-2020 64

TABLE 52 Global Cancer Research Institutes Segment Market Share, By Region 2021-2031 64

TABLE 53 Global Cancer Research Institutes Segment Y-o-Y, By Region 2015-2031 64

TABLE 54 Global Others Segment Value (US$ Mn), By Region 2016-2020 65

TABLE 55 Global Others Segment Value (US$ Mn), By Region 2021-2031 66

TABLE 56 Global Others Segment Market Share, By Region 2016-2020 67

TABLE 57 Global Others Segment Market Share, By Region 2021-2031 67

TABLE 58 Global Others Segment Y-o-Y, By Region 2015-2031 67

TABLE 59 Global Non Small-cell Lung Cancer Segment Value (US$ Mn), By Region 2016-2020 69

TABLE 60 Global Non Small-cell Lung Cancer Segment Value (US$ Mn), By Region 2021-2031 70

TABLE 61 Global Non Small-cell Lung Cancer Segment Market Share, By Region 2016-2020 71

TABLE 62 Global Non Small-cell Lung Cancer Segment Market Share, By Region 2021-2031 71

TABLE 63 Global Non Small-cell Lung Cancer Segment Y-o-Y, By Region 2015-2031 71

TABLE 64 Global Small-cell Lung Cancer Segment Value (US$ Mn), By Region 2016-2020 72

TABLE 65 Global Small-cell Lung Cancer Segment Value (US$ Mn), By Region 2021-2031 73

TABLE 66 Global Small-cell Lung Cancer Segment Market Share, By Region 2016-2020 74

TABLE 67 Global Small-cell Lung Cancer Segment Market Share, By Region 2021-2031 74

TABLE 68 Global Small-cell Lung Cancer Segment Y-o-Y, By Region 2015-2031 74

TABLE 69 North America Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 76

TABLE 70 North America Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 77

TABLE 71 North America Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 78

TABLE 72 North America Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 78

TABLE 73 North America Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 79

TABLE 74 North America Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 80

TABLE 75 Latin America Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 81

TABLE 76 Latin America Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 82

TABLE 77 Latin America Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 83

TABLE 78 Latin America Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 83

TABLE 79 Latin America Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 84

TABLE 80 Latin America Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 85

TABLE 81 Europe Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 86

TABLE 82 Europe Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 87

TABLE 83 Europe Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 88

TABLE 84 Europe Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 88

TABLE 85 Europe Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 89

TABLE 86 Europe Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 90

TABLE 87 Japan Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 91

TABLE 88 Japan Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 92

TABLE 89 Japan Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 93

TABLE 90 Japan Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 93

TABLE 91 Japan Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 94

TABLE 92 Japan Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 95

TABLE 93 APEJ Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 96

TABLE 94 APEJ Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 97

TABLE 95 APEJ Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 98

TABLE 96 APEJ Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 98

TABLE 97 APEJ Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 99

TABLE 98 APEJ Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 100

TABLE 99 MEA Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 101

TABLE 100 MEA Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 102

TABLE 101 MEA Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 103

TABLE 102 MEA Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 103

TABLE 103 MEA Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 104

TABLE 104 MEA Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 105

TABLE 105 US Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 107

TABLE 106 US Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 107

TABLE 107 US Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 108

TABLE 108 US Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 108

TABLE 109 US Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 108

TABLE 110 US Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 109

TABLE 111 Canada Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 109

TABLE 112 Canada Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 110

TABLE 113 Canada Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 110

TABLE 114 Canada Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 111

TABLE 115 Canada Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 111

TABLE 116 Canada Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 111

TABLE 117 Brazil Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 113

TABLE 118 Brazil Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 113

TABLE 119 Brazil Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 114

TABLE 120 Brazil Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 114

TABLE 121 Brazil Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 114

TABLE 122 Brazil Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 115

TABLE 123 Mexico Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 115

TABLE 124 Mexico Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 116

TABLE 125 Mexico Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 116

TABLE 126 Mexico Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 117

TABLE 127 Mexico Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 117

TABLE 128 Mexico Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 117

TABLE 129 Argentina Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 118

TABLE 130 Argentina Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 118

TABLE 131 Argentina Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 119

TABLE 132 Argentina Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 119

TABLE 133 Argentina Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 120

TABLE 134 Argentina Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 120

TABLE 135 Germany Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 121

TABLE 136 Germany Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 121

TABLE 137 Germany Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 122

TABLE 138 Germany Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 122

TABLE 139 Germany Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 123

TABLE 140 Germany Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 123

TABLE 141 UK Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 123

TABLE 142 UK Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 124

TABLE 143 UK Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 124

TABLE 144 UK Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 125

TABLE 145 UK Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 125

TABLE 146 UK Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 125

TABLE 147 France Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 126

TABLE 148 France Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 126

TABLE 149 France Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 127

TABLE 150 France Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 127

TABLE 151 France Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 128

TABLE 152 France Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 128

TABLE 153 Spain Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 128

TABLE 154 Spain Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 129

TABLE 155 Spain Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 129

TABLE 156 Spain Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 130

TABLE 157 Spain Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 130

TABLE 158 Spain Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 130

TABLE 159 Italy Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 131

TABLE 160 Italy Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 131

TABLE 161 Italy Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 132

TABLE 162 Italy Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 132

TABLE 163 Italy Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 133

TABLE 164 Italy Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 133

TABLE 165 Nordic Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 133

TABLE 166 Nordic Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 134

TABLE 167 Nordic Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 134

TABLE 168 Nordic Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 135

TABLE 169 Nordic Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 135

TABLE 170 Nordic Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 135

TABLE 171 Japan  Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 137

TABLE 172 Japan  Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 137

TABLE 173 Japan  Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 138

TABLE 174 Japan  Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 138

TABLE 175 Japan  Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 138

TABLE 176 Japan  Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 139

TABLE 177 China Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 140

TABLE 178 China Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 140

TABLE 179 China Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 141

TABLE 180 China Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 141

TABLE 181 China Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 141

TABLE 182 China Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 142

TABLE 183 India Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 142

TABLE 184 India Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 143

TABLE 185 India Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 143

TABLE 186 India Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 144

TABLE 187 India Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 144

TABLE 188 India Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 144

TABLE 189 Malaysia Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 145

TABLE 190 Malaysia Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 145

TABLE 191 Malaysia Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 146

TABLE 192 Malaysia Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 146

TABLE 193 Malaysia Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 147

TABLE 194 Malaysia Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 147

TABLE 195 Thailand Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 147

TABLE 196 Thailand Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 148

TABLE 197 Thailand Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 148

TABLE 198 Thailand Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 149

TABLE 199 Thailand Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 149

TABLE 200 Thailand Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 149

TABLE 201 Singapore Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 150

TABLE 202 Singapore Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 150

TABLE 203 Singapore Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 151

TABLE 204 Singapore Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 151

TABLE 205 Singapore Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 152

TABLE 206 Singapore Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 152

TABLE 207 Australia Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 153

TABLE 208 Australia Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 153

TABLE 209 Australia Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 154

TABLE 210 Australia Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 154

TABLE 211 Australia Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 154

TABLE 212 Australia Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 155

TABLE 213 GCC Countries Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 156

TABLE 214 GCC Countries Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 156

TABLE 215 GCC Countries Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 157

TABLE 216 GCC Countries Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 157

TABLE 217 GCC Countries Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 158

TABLE 218 GCC Countries Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 158

TABLE 219 South Africa Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 158

TABLE 220 South Africa Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 159

TABLE 221 South Africa Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 159

TABLE 222 South Africa Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 160

TABLE 223 South Africa Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 160

TABLE 224 South Africa Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 160

TABLE 225 Nigeria Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 161

TABLE 226 Nigeria Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 161

TABLE 227 Nigeria Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 162

TABLE 228 Nigeria Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 162

TABLE 229 Nigeria Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 163

TABLE 230 Nigeria Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 163

TABLE 231 Israel Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 163

TABLE 232 Israel Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 164

TABLE 233 Israel Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 164

TABLE 234 Israel Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 165

TABLE 235 Israel Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 165

TABLE 236 Israel Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 165

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

FIG. 1 Global Lung Cancer Diagnostics Market Value (US$ Mn), 2016-2020 18

FIG. 2 Global Lung Cancer Diagnostics Market Value (US$ Mn) Forecast, 2021-2031 18

FIG. 3 Global Lung Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2015-2031 20

FIG. 4 Global CA Test Segment Market Value (US$ Mn) By Region, 2016-2020 22

FIG. 5 Global CA Test Segment Market Value (US$ Mn) By Region, 2021-2031 23

FIG. 6 Global CA Test Segment Y-o-Y Growth Rate, By Region, 2015-2031 25

FIG. 7 Global HER2 Tests Segment Market Value (US$ Mn) By Region, 2016-2020 25

FIG. 8 Global HER2 Tests Segment Market Value (US$ Mn) By Region, 2021-2031 26

FIG. 9 Global HER2 Tests Segment Y-o-Y Growth Rate, By Region, 2015-2031 28

FIG. 10 Global ALK Tests Segment Market Value (US$ Mn) By Region, 2016-2020 28

FIG. 11 Global ALK Tests Segment Market Value (US$ Mn) By Region, 2021-2031 29

FIG. 12 Global ALK Tests Segment Y-o-Y Growth Rate, By Region, 2015-2031 31

FIG. 13 Global Angiogenesis Inhibitor Segment Market Value (US$ Mn) By Region, 2016-2020 31

FIG. 14 Global Angiogenesis Inhibitor Segment Market Value (US$ Mn) By Region, 2021-2031 32

FIG. 15 Global Angiogenesis Inhibitor Segment Y-o-Y Growth Rate, By Region, 2015-2031 34

FIG. 16 Global EGFR Mutation Tests Segment Market Value (US$ Mn) By Region, 2016-2020 34

FIG. 17 Global EGFR Mutation Tests Segment Market Value (US$ Mn) By Region, 2021-2031 35

FIG. 18 Global EGFR Mutation Tests Segment Y-o-Y Growth Rate, By Region, 2015-2031 37

FIG. 19 Global KRAS Mutation Tests Segment Market Value (US$ Mn) By Region, 2016-2020 37

FIG. 20 Global KRAS Mutation Tests Segment Market Value (US$ Mn) By Region, 2021-2031 38

FIG. 21 Global KRAS Mutation Tests Segment Y-o-Y Growth Rate, By Region, 2015-2031 40

FIG. 22 Global Others Segment Market Value (US$ Mn) By Region, 2016-2020 40

FIG. 23 Global Others Segment Market Value (US$ Mn) By Region, 2021-2031 41

FIG. 24 Global Others Segment Y-o-Y Growth Rate, By Region, 2015-2031 43

FIG. 25 Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2016-2020 44

FIG. 26 Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2021-2031 45

FIG. 27 Global Hospital Associated Labs Segment Y-o-Y Growth Rate, By Region, 2015-2031 47

FIG. 28 Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2016-2020 47

FIG. 29 Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2021-2031 48

FIG. 30 Global Independent Diagnostic Laboratories Segment Y-o-Y Growth Rate, By Region, 2015-2031 50

FIG. 31 Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2016-2020 50

FIG. 32 Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2021-2031 51

FIG. 33 Global Cancer Research Institutes Segment Y-o-Y Growth Rate, By Region, 2015-2031 53

FIG. 34 Global Others Segment Market Value (US$ Mn) By Region, 2016-2020 53

FIG. 35 Global Others Segment Market Value (US$ Mn) By Region, 2021-2031 54

FIG. 36 Global Others Segment Y-o-Y Growth Rate, By Region, 2015-2031 56

FIG. 37 Global Non Small-cell Lung Cancer Segment Market Value (US$ Mn) By Region, 2016-2020 57

FIG. 38 Global Non Small-cell Lung Cancer Segment Market Value (US$ Mn) By Region, 2021-2031 58

FIG. 39 Global Non Small-cell Lung Cancer Segment Y-o-Y Growth Rate, By Region, 2015-2031 60

FIG. 40 Global Small-cell Lung Cancer Segment Market Value (US$ Mn) By Region, 2016-2020 60

FIG. 41 Global Small-cell Lung Cancer Segment Market Value (US$ Mn) By Region, 2021-2031 61

FIG. 42 Global Small-cell Lung Cancer Segment Y-o-Y Growth Rate, By Region, 2015-2031 63

FIG. 43 North America Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 64

FIG. 44 North America Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 65

FIG. 45 North America Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 66

FIG. 46 North America Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 67

FIG. 47 North America Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 68

FIG. 48 North America Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 68

FIG. 49 Latin America Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 69

FIG. 50 Latin America Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 70

FIG. 51 Latin America Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 71

FIG. 52 Latin America Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 72

FIG. 53 Latin America Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 73

FIG. 54 Latin America Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 73

FIG. 55 Europe Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 74

FIG. 56 Europe Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 75

FIG. 57 Europe Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 76

FIG. 58 Europe Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 77

FIG. 59 Europe Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 78

FIG. 60 Europe Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 78

FIG. 61 Japan Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 79

FIG. 62 Japan Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 80

FIG. 63 Japan Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 81

FIG. 64 Japan Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 82

FIG. 65 Japan Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 83

FIG. 66 Japan Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 83

FIG. 67 APEJ Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 84

FIG. 68 APEJ Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 85

FIG. 69 APEJ Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 86

FIG. 70 APEJ Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 87

FIG. 71 APEJ Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 88

FIG. 72 APEJ Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 88

FIG. 73 MEA Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 89

FIG. 74 MEA Lung Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 90

FIG. 75 MEA Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 91

FIG. 76 MEA Lung Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 92

FIG. 77 MEA Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2016-2020 93

FIG. 78 MEA Lung Cancer Diagnostics Market Value (US$ Mn), By Indication 2021-2031 93

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Lung Cancer Diagnostics Market

Schedule a Call

Copyright © Fact.MR All Rights Reserved

An initiative of Eminent Research and Advisory Services

Google translate